NCT03414632View on ClinicalTrials.gov

Transthyretin Cardiac Amyloidosis in HFpEF

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

287

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

March 31, 2020

Study Completion Date

March 31, 2020

Conditions

Heart Failure With Preserved Ejection Fraction

Interventions

DRUG

99mTc-PYP

Radioisotope used in the SPECT/CT imaging

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

Mayo Clinic

OTHER